As expected, a petition for review was filed last week in the latest class certification/collateral estoppel case, Johnson v. GlaxoSmithKline, Inc., no. S167892.
Here is my original post on the Court of Appeal's opinion, Johnson v. GlaxoSmithKline, Inc., 166 Cal.App.4th 1497 (2008) (modified Oct. 14, 2008) (Second Appellate District, Division Seven).
Comments